Trials / Unknown
UnknownNCT00515996
Genetic Abnormalities and Biological Changes of Panic Disorder Patients After Pharmacotherapy
Genetic Abnormalities and Changes of Autonomic Nervous System, Serotonin System, and Neuroendocrine System According to Pharmacotherapy in Panic Disorder
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (estimated)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
We plan to examine genetic polymorphism of catechol-O-methyltransferase in panic disorder and neurobiological changes of panic disorder patients after 12 weeks of pharmacotherapy with paroxetine. We plan to include 40 panic disorder patients and 40 normal control subjects in this study for 3 years.
Conditions
Timeline
- Start date
- 2006-01-01
- Completion
- 2008-12-01
- First posted
- 2007-08-14
- Last updated
- 2007-08-14
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00515996. Inclusion in this directory is not an endorsement.